EDMOND BABINEAU: Open Payments
NPI 1568841781 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 44 payments from 12 companies in 2025. Trend: 2023 $850 · 2024 $1,132 · 2025 $909
Food & beverage: $844Education: $65
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $270 |
| UCB, Inc. | 6 | $132 |
| Organon LLC | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| ABBVIE INC. | 4 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $67 |
| Incyte Corporation | 3 | $65 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Botanix SB Inc | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: TREMFYA, Bimzelx, DUPIXENT, OPZELURA, BOTOX, ILUMYA, NEMLUVIO, VTAMA.
Industry payments across PA — which companies pay providers there.
